
|
Taken from WWW.pubmed.gov
Menopause. 2007 Mar-Apr;14(2):183-90.
Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women.
Hofling M, Hirschberg AL, Skoog L, Tani E, Hägerström T, von Schoultz B.
OBJECTIVE: During the past few years serious concern has been raised about the safety of combined estrogen/progestogen hormone therapy, in
particular about its effects on the breast. Several observations suggest that androgens may counteract the proliferative effects of estrogen and progestogen
in the mammary gland. Thus, we aimed to study the effects of testosterone addition on breast cell proliferation during postmenopausal estrogen/progestogen
therapy. DESIGN: We conducted a 6-month prospective, randomized, double-blind, placebo-controlled study. A total of 99 postmenopausal women were given
continuous combined estradiol 2 mg/norethisterone acetate 1 mg and were equally randomly assigned to receive additional treatment with either a testosterone
patch releasing 300 microg/24 hours or a placebo patch. Breast cells were collected by fine needle aspiration biopsy at baseline and after 6 months, and the main
outcome measure was the percentage of proliferating breast cells positively stained by the Ki-67/MIB-1 antibody.
|